The similarity between alkaline phosphatase (EC 3.1.3.1) and phytase (EC 3.1.3.8) activities in rat intestine and their importance in phytate-induced zinc deficiency

1978 ◽  
Vol 39 (2) ◽  
pp. 307-316 ◽  
Author(s):  
N. T. Davies ◽  
A. A. Flett

1. The activities of alkaline phosphatase (EC 3.1.3.1) and phytase (EC3.1.3.8) were similarly distributed in the small intestine of rats. Regional differences in activity were reflected by similar differences in the capacity of ligated intestinal segments to hydrolyse phytate in vivo. Activities were greatest in the duodenum and lowest in the terminal ileum.2. Specific activities of both enzymes were tenfold greater in the brush border fraction of duodenal mucosa compared with entire mucosal homogenates.3. Brush-border alkaline phosphatase and phytase activities required both magnesium and zinc ions for maximal activity.4. Zn deficiency induced by feeding a diet low in Zn (0.5 mg Zn/kg) caused similar reductions in activity of both enzymes.5. Zn deficiency induced by feeding diets marginally adequate in Zn (12 mg/kg) and phytate (10g/kg) caused reductions in alkaline phosphatase, phytase activities and phytate hydrolysis in vivo.6. It is suggested that phytase activity is a manifestation of alkaline phosphatase and the significance of this in relation to phytate-induced Zn deficiency is discussed.

2001 ◽  
Vol 281 (1) ◽  
pp. G159-G163 ◽  
Author(s):  
Maltin Repishti ◽  
Daniel L. Hogan ◽  
Vijaya Pratha ◽  
Laura Davydova ◽  
Mark Donowitz ◽  
...  

The proximal duodenal mucosa secretes HCO[Formula: see text] that serves to protect the epithelium from injury. In isolated human duodenal enterocytes in vitro, multiple luminal membrane proteins are involved in acid/base transport. We postulated that one or more isoforms of the Na+/H+ exchanger (NHE) family is located on the apical surface of human duodenal mucosal epithelial cells and thereby contributes to duodenal mucosal HCO[Formula: see text] transport. Duodenal biopsies were obtained from human volunteers, and the presence of NHE2 and NHE3 was determined by using previously characterized polyclonal antibodies (Ab 597 for NHE2 and Ab 1381 for NHE3). In addition, proximal duodenal mucosal HCO[Formula: see text] transport was measured in humans in vivo in response to luminal perfusion of graded doses of amiloride; 10−5–10−4 M amiloride was used to inhibit NHE2 and 10−3 M amiloride to inhibit NHE3. Both NHE2 and NHE3 were localized principally to the brush border of duodenal villus cells. Sequential doses of amiloride resulted in significant, step-wise increases in net duodenal HCO[Formula: see text] output. Inhibition of NHE2 with 10−5 M and 10−4 M amiloride significantly increased net HCO[Formula: see text] output. Moreover, there was an additional, equivalent increase ( P < 0.05) in duodenal HCO[Formula: see text] output with 10−3 M amiloride, which inhibited NHE3. We conclude that 1) NHE2 and NHE3 are localized principally to the brush border of human duodenal villus epithelial cells; 2) sequential inhibition of NHE2 and NHE3 isoforms resulted in step-wise increases in net HCO[Formula: see text]output; 3) NHE2 and NHE3 participate in human duodenal villus cell HCO[Formula: see text] transport; and 4) the contribution of NHE-related transport events should be considered when studying duodenal HCO[Formula: see text] transport processes.


Bone ◽  
2006 ◽  
Vol 38 (5) ◽  
pp. S16-S17 ◽  
Author(s):  
M.L. Brance ◽  
R.M. Brun ◽  
A. Rigalli ◽  
L. De Candia ◽  
R.C. Puche

1981 ◽  
Vol 47 (1) ◽  
pp. 227-236
Author(s):  
P.R. Hearn ◽  
R.G. Russell ◽  
J. Farmer

An electron-microscopic study of various fractions taken during a newly developed method for preparation of brush border vesicles from rat duodenum, has shown that vesiculation of microvilli can occur in situ on the brush border membrane. This mode of formation ensures that the vesicle membranes are oriented as in vivo and that they are “right-side-out”. The disruption of core protein-fibres appears to be a prerequisite for vesicle formation.


1981 ◽  
Vol 200 (3) ◽  
pp. 645-654 ◽  
Author(s):  
Graeme P. Young ◽  
Steven T. Yedlin ◽  
David H. Alpers

Enzymically active intestinal alkaline phosphatase exists in both soluble and membrane-bound forms in the suckling rat. Antiserum prepared against purified soluble alkaline phosphatase (anti-AlP) was shown to be monospecific when assessed by Ouchterlony double-diffusion analysis and immunoelectrophoresis. The two forms of alkaline phosphatase were antigenically identical and possessed similar affinities for anti-AlP. To study the biosynthesis of the two forms, 14-day-old rats were injected intraperitoneally with [3H]leucine. The labelling kinetics of alkaline phosphatase, extracted from supernatant and brush-border membrane fractions with anti-AlP, was followed over 20h. Incorporation of [3H]leucine into membrane-bound alkaline phosphatase was rapid, reaching a plateau at 6h. The soluble enzyme showed slower incorporation of label and maximal radioactivity was not reached until 12h after labelling, a lag of 6h behind the membrane-bound enzyme. Soluble alkaline phosphatase could not have been a precursor of the membrane form, as there was no early peak of radioactivity in the soluble form. To determine if the soluble enzyme was irreversibly derived from the membrane enzyme, a newly developed technique of labelling brush-border membrane proteins in vivo by intraluminal injection of diazotized [125I]iodosulphanilic acid was used. The appearance of 125I in soluble and membrane alkaline phosphatase was then monitored over a 7h period, encompassing the lag between maximal leucine labelling of the two forms. The results failed to show either a proportional transfer of radioactivity from membrane to soluble alkaline phosphatase or an absolute increase in radioactivity of the soluble form during degradation of brush-border alkaline phosphatase. Therefore there does not appear to be a serial precursor/product relationship between the soluble and membrane-bound forms of suckling-rat intestinal alkaline phosphatase.


1981 ◽  
Vol 59 (4) ◽  
pp. 311-323 ◽  
Author(s):  
Claude PetitClerc ◽  
Gérard E. Plante

A new aspect in the study of mechanisms involved in the renal transport of phosphate, the role of alkaline phosphatase (ALP), was introduced by this laboratory in 1977. The present experiments were designed to examine the effects of levamisole, a known inhibitor of ALP, first on in vitro phosphotransferase activity of rat brush border ALP and second on in vivo transport of phosphate and other ionic species, using both clearance and micropuncture techniques.The results indicate that levamisole inhibits in vitro ALP of brush borders obtained from kidney cortex of dogs and rats by reducing the turnover of orthophosphate on the enzyme. When administered in vivo this drug inhibits the net reabsorption of phosphate in these two different mammalian species. Tubular reabsorption of phosphate falls from 87.0 ± 2.9 to 72.1 ± 3.5% when levamisole is administered in the dog femoral vein (25 mM) and from 85.1 ± 3.4 to 71.3 ± 3.2% when levamisole is infused in the dog renal artery (2.5 mM). In the intact rat this parameter falls from 96.7 ± 1.4 to 46.8 ± 9.8% during levamisole and it also decreases from 98.9 ± 0.8 to 67.4 ± 6.7% in the thyroparathyroidectomized animal. The effect of levamisole on the net tubular transport of phosphate is closely related (r = 0.967) to the amount of the drug reaching the tubular lumen from glomerular filtration: that fraction of administered levamisole which first reaches the early segments of the proximal tubule, where the bulk of filtered phosphate is normally reabsorbed.The effect of levamisole appears to be specific for phosphate as no change in the net transport of other ionic species could be documented in the dog experiments. Levamisole produces a significant decrement in renal plasma flow. The mechanism of this effect is not yet determined but certainly created a situation leading to underestimation of the levamisole effect on the net tubular transport of phosphate.Microinjections of 32P either diluted in isotonic saline or administered with flavone phosphate (0.2 mM), a substrate of ALP, were performed in early segments of superficial proximal tubules of the rat. Urinary 32 P recovery averaged 14 ± 4% and 34 ± 8% following saline and flavone phosphate, respectively.The effect of levamisole does not appear to be mediated by changes in parathyroid hormone secretion or other extrarenal humoral substances as a depression of phosphate reabsorption is seen when the drug is administered in the renal artery. The rapid and reversible effect of flavone phosphate suggests that this compound specifically interacts with ALP of brush border membranes.


2007 ◽  
Vol 293 (6) ◽  
pp. G1223-G1233 ◽  
Author(s):  
Yasutada Akiba ◽  
Misa Mizumori ◽  
Paul H. Guth ◽  
Eli Engel ◽  
Jonathan D. Kaunitz

We hypothesized that duodenal HCO3− secretion alkalinizes the microclimate surrounding intestinal alkaline phosphatase (IAP), increasing its activity. We measured AP activity in rat duodenum in situ in frozen sections with the fluorogenic substrate ELF-97 phosphate and measured duodenal HCO3− secretion with a pH-stat in perfused duodenal loops. We examined the effects of the IAP inhibitors l-cysteine or l-phenylalanine (0.1–10 mM) or the tissue nonspecific AP inhibitor levamisole (0.1–10 mM) on AP activity in vitro and on acid-induced duodenal HCO3− secretion in vivo. AP activity was the highest in the duodenal brush border, decreasing longitudinally to the large intestine with no activity in stomach. Villous surface AP activity measured in vivo was enhanced by PGE2 intravenously and inhibited by luminal l-cysteine. Furthermore, incubation with a pH 2.2 solution reduced AP activity in vivo, whereas pretreatment with the cystic fibrosis transmembrane regulator (CFTR) inhibitor CFTRinh-172 abolished AP activity at pH 2.2. l-Cysteine and l-phenylalanine enhanced acid-augmented duodenal HCO3− secretion. The nonselective P2 receptor antagonist suramin (1 mM) reduced acid-induced HCO3− secretion. Moreover, l-cysteine or the competitive AP inhibitor glycerol phosphate (10 mM) increased HCO3− secretion, inhibited by suramin. In conclusion, enhancement of the duodenal HCO3− secretory rate increased AP activity, whereas inhibition of AP activity increased the HCO3− secretory rate. These data support our hypothesis that HCO3− secretion increases AP activity by increasing local pH at its catalytic site and that AP hydrolyzes endogenous luminal phosphates, presumably ATP, which increases HCO3− secretion via activation of P2 receptors.


Sign in / Sign up

Export Citation Format

Share Document